![Hironori Narita](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Hironori Narita
Entité | Type d'entité | Industrie | |
---|---|---|---|
DCI Partners KK
![]() DCI Partners KK Investment ManagersFinance DCI Partners KK (DCI Partners) is a venture arm of Daiwa Corporate Investment Co., Ltd. founded in 2014. The firm is headquartered in Tokyo, Japan.
4
| Subsidiary | Investment Managers | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Hironori Narita via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
HOGY MEDICAL CO.,LTD. | Medical Specialties | Director/Board Member | |
AGP KK | Founder | ||
ASANTE INCORPORATED | Miscellaneous Commercial Services | Director/Board Member | |
KIDSWELL BIO CORPORATION | Biotechnology | Director/Board Member | |
Junten Bio Co. Ltd.
![]() Junten Bio Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Junten Bio Co. Ltd. is a Japanese company founded in 2018 that engages in research and development of cell and regenerative medicines. The company is based in Chuo-ku, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
NOILE-IMMUNE BIOTECH INC. | Pharmaceuticals: Major | Director/Board Member | |
REGiMMUNE Corp.
![]() REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
University of Tsukuba | College/University | Graduate Degree | |
Tokyo University of Science | College/University | Graduate Degree | |
Daiwa Corporate Investment Co., Ltd.
![]() Daiwa Corporate Investment Co., Ltd. Investment ManagersFinance Daiwa Corporate Investment Co. Ltd. (Daiwa Corporate Investment) is a private equity arm of Daiwa Securities Group Inc. and is headquartered in Tokyo, Japan. The firm was founded in 1982. | Investment Managers | Comptroller/Controller/Auditor |
Statistiques
Internationale
Japon | 11 |
Sectorielle
Health Technology | 5 |
Commercial Services | 3 |
Consumer Services | 3 |
Finance | 2 |
Opérationnelle
Director/Board Member | 10 |
Private Equity Investor | 3 |
Independent Dir/Board Member | 2 |
Graduate Degree | 2 |
Comptroller/Controller/Auditor | 2 |
Relations les plus connectées
- Bourse
- Insiders
- Hironori Narita
- Connexions Sociétés